Raffles Medical Group Ltd

Equities

BSL

SG1CH4000003

Healthcare Facilities & Services

Market Closed - Singapore S.E. Other stock markets 05:04:33 2024-04-26 am EDT			5-day change	1st Jan Change
1.01 ^SGD	-0.98%		0.00%	-6.48%

Apr. 26	Raffles Medical Group Ltd Approves One-Tier Tax Exempt Final Dividend for the Year Ended 31 December 2023, Payable on May 23, 2024	CI
Apr. 03	Raffles Medical Group Ltd Proposes Final Dividend for the Year Ended 31 December 2023, Payable on May 23, 2024	CI

Raffles Medical Group Ltd Announces Appointment of Lu Liangjian as Non-Executive and Non-Independent Director

July 31, 2023 at 07:48 am EDT

Raffles Medical Group Ltd. announced appointment of Dr. Lu Liangjian as Non-Executive and Non-Independent Director. Working Experience: Associate Consultant (from 13 February 2023) Department of Paediatrics National University Hospital Singapore Senior Resident (2020 - 12 February 2023) Department of Paediatrics National University Hospital Singapore Resident (2016 - 2019) Department of Paediatrics National University Hospital Singapore. Other DirectorShips Past: Resident/Senior Resident, National University Hospital Singapore.

Other DirectorShips Present: Director, S & D Holdings Pte Ltd. Professional Qualifications: National University of Singapore - Master of Medicine (Paediatric Medicine) (2019) Membership of the Royal College of Paediatrics and Child Health (2019) University of Cambridge - Master of Arts (2017) - MB BChir (2016) - Bachelor of Arts (Honours) (First Class) (2013).

Latest news about Raffles Medical Group Ltd

Raffles Medical Group Ltd Approves One-Tier Tax Exempt Final Dividend for the Year Ended 31 December 2023, Payable on May 23, 2024	Apr. 26	CI
Raffles Medical Group Ltd Proposes Final Dividend for the Year Ended 31 December 2023, Payable on May 23, 2024	Apr. 03	CI
Raffles Medical Group Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 03	CI
CGS-CIMB Research Adjusts Raffles Medical Group’s Price Target to SG$1.16 From SG$1.20, Keeps at Buy	Feb. 29	MT
PhillipCapital Adjusts Raffles Medical Group’s Price Target to SG$0.96 From SG$1.02, Keeps at Neutral	Feb. 29	MT
Maybank Securities Adjusts Raffles Medical Group’s Price Target to SG$1.15 From SG$1.30, Keeps at Hold	Feb. 29	MT
Raffles Medical’s Attributable Profit in H2 2023 Plunges 64%; Shares Down 4%	Feb. 25	MT
Raffles Medical Buys Back Shares	Dec. 12	MT
Raffles Medical Buys Back Shares	Dec. 08	MT
Raffles Medical Buys Back Shares	Dec. 07	MT
Explainer-What do we know about China's respiratory illness surge?	Dec. 01	RE
Raffles Medical Buys Back Shares	Nov. 24	MT
Raffles Medical Group Repurchases Shares	Nov. 21	MT
CGS-CIMB Research Adjusts Raffles Medical Group's Price Target to SG$1.20 From SG$1.77, Keeps at Add	Nov. 09	MT
DBS Group Research Adjusts Raffles Medical Group's Price Target to SG$1.00 From SG$1.48, Keeps at Hold	Nov. 09	MT
Maybank Securities Downgrades Raffles Medical Group to Hold From Buy, Adjusts Price Target to SG$1.30 From SG$1.65	Nov. 09	MT
RHB Bank Singapore Downgrades Raffles Medical Group to Neutral From Buy, Adjusts Price Target to SG$1.15 From SG$1.75	Nov. 09	MT
PhillipCapital Research Downgrades Raffles Medical Group to Neutral From Buy, Adjusts Price Target to SG$1.02 From SG$1.76	Nov. 09	MT
Raffles Medical Buys Back Shares	Nov. 08	MT
Nomura Adjusts Raffles Medical’s Price Target to SG$1.40 From SG$1.60, Keeps at Buy	Nov. 07	MT
Raffles Medical Group Ltd commences an Equity Buyback Plan for 186,006,062 shares, representing 10% of its issued share capital, under the authorization approved on April 28, 2023.	Nov. 07	CI
Singapore Index Soars Over 1%; DBS Group Shares Climb 1% on Posting 18% Increase in Q3 Net Profit	Nov. 06	MT
Raffles Medical's Profit Falls 67% in Q3; Shares Drop 8%	Nov. 05	MT
Raffles Medical Group Utilizes Treasury Shares Upon Vesting of Share Awards	23-10-06	MT
Raffles Medical to Acquire Majority Stake in Vietnamese Hospital	23-10-03	MT

Chart Raffles Medical Group Ltd

Duration

Period

More charts

Company Profile

Raffles Medical Group Ltd is a Singapore-based integrated private healthcare provider. The principal activities of the Company are those relating to the operation of medical clinics, other general medical services, and investment holdings. The Companyâs segments include Healthcare Services, Hospital Services, and Investment Holdings. The Healthcare Services segment is engaged in the operations of medical clinics and other general medical services; provision of health insurance, trading in pharmaceutical and nutraceutical products and diagnostic equipment, and provision of management and consultancy services. The Hospital Services segment is engaged in the provision of specialized medical services and operation of hospital and business of medical laboratory and imaging center. The Investment Holdings segment is engaged in investment holding and those relating to investment properties. It operates medical facilities in about 14 cities in Singapore, China, Japan, Vietnam, and Cambodia.

Sector

Healthcare Facilities & Services

Calendar

2024-05-12 - Ex-dividend day for final dividend

More about the company